
What We're Reading: Omicron Variant Response; Lung Transplants for Patients With COVID-19; Panel to Review Merck’s COVID-19 Pill
President Joe Biden will provide an update today on his administration’s response to the Omicron COVID-19 variant; marked rise in lung transplants for patients with COVID-19 sparks ethical questions; an independent panel of experts will advise FDA tomorrow on the use of Merck’s COVID-19 antiviral pill.
President Biden to Announce US Response to Omicron Variant
As travel restrictions for travelers from several African countries take effect, President Joe Biden is set to provide an update today on his administration’s response to the Omicron COVID-19 variant. As reported by
Lung Transplants Increasing for Patients With COVID-19
According to data from the United Network for Organ Sharing, lung transplants in the United States rose 10-fold between the first year of the pandemic and 2021, with approximately 1 in 10 lung transplants performed on patients with COVID-19. As reported by
Independent Panel to Advise FDA on Merck’s COVID-19 Pill
As reported by
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.